SGLT2 Inhibitors and the Cardiorenal Continuum: A Paradigm Shift in the Treatment of Patients With T2D [PDF]
Diabetes Therapy, 2022 Type 2 diabetes mellitus (T2D) represents a sig- nificant public health problem, with a dramat- ically increasing prevalence. T2D is considered a progressive disease that develops macro- and microvascular complications such as cardiovas- cular disease (CVD), heart failure (HF), and chronic kidney disease (CKD), which are closely interconnected and ...
Javier Escalada
exaly +7 more sources
Cardiovascular and Renal Links along the Cardiorenal Continuum [PDF]
International Journal of Nephrology, 2011 The cardiorenal syndrome includes the widely known relationship between kidney function and cardiovascular disease. A large number of patients have various degrees of heart and kidney dysfunction worldwide, both in developed and developing countries ...
José A. García-Donaire +1 more
doaj +8 more sources
CARDIORENAL SYNDROME IN PATIENTS WITH CHRONIC HEART FAILURE AS A STAGE OF THE CARDIORENAL CONTINUUM (PART I): DEFINITION, CLASSIFICATION, PATHOGENESIS, DIAGNOSIS, EPIDEMIOLOGY [PDF]
Архивъ внутренней медицины, 2019 The combination of heart failure and renal failure is called cardiorenal syndrome. It is a stage of the cardiorenal continuum and, possibly, a small link of the cardiorenal-cerebral-metabolic axis.
E. V. Reznik, I. G. Nikitin
doaj +4 more sources
Cardiorenal syndrome in patients with heart failure as a stage of the cardiorenal continuum (part 2): prognosis, prevention and treatment [PDF]
Архивъ внутренней медицины, 2019 Cardiorenal syndrome in patients with heart failure is a regular link in the chain of cardiorenal continuum. Physicians of various specialties may encounter patients with cardiorenal syndrome: general practitioners, cardiologists, nephrologists ...
E. V. Reznik, I. G. Nikitin
doaj +4 more sources
Tirzepatide and the Cardiovascular Continuum: Metabolic, Cardiorenal and Heart Failure Evidence [PDF]
Clinical Medicine Insights: CardiologyTirzepatide is a first-in-class, once-weekly dual GIP and GLP-1 receptor agonist approved for type 2 diabetes and obesity. Given the tight link between hyperglycemia, adiposity, and cardiovascular disease, tirzepatide has rapidly gained interest as a ...
Antonio LM Parlati MD +6 more
doaj +4 more sources
The Next-Generation CKD Heat Map: Hyperfiltration and eGFR Slope in the Cardiorenal Continuum [PDF]
Kidney International ReportsHiroshi Kataoka +3 more
doaj +3 more sources
Updated Pathways in Cardiorenal Continuum after Kidney Transplantation
Transplantology, 2022 Cardiovascular disease (CVD) remains one of the leading causes for increased morbidity and mortality in chronic kidney disease (CKD). Kidney transplantation is the preferred treatment option for CKD G5.
Agnė Laučytė-Cibulskienė +3 more
doaj +2 more sources
The unified cardiometabolic disease continuum: mechanistic stages of a single pathophysiological process [PDF]
Frontiers in EndocrinologyBackgroundType 2 diabetes mellitus (T2DM), atherosclerotic cardiovascular disease (ASCVD), heart failure with preserved ejection fraction (HFpEF), metabolic dysfunction-associated steatotic liver disease (MASLD), hypertension, and chronic kidney disease (
Luz María Quirino-Vela +6 more
doaj +2 more sources
Chronic kidney disease and atrial fibrillation as components of the cardiorenal continuum [PDF]
Терапевтический архив, 2016 The paper discusses the present-day idea on a relationship between atrial fibrillation and chronic kidney disease, the specific features of therapeutic policy, and the place of antithrombotic therapy in particular.
N A Mukhin +4 more
doaj +3 more sources
RENAL ARTERIES REMODELLING — THE INITIATOR AND TARGET OF CARDIORENAL CONTINUUM
Кардиоваскулярная терапия и профилактика, 2015 Cardiorenal syndrome (CRS) is one of the most important problems in contemporary medicine, due to high values of morbidity and mortality from cardiovascular and renal systems.
T. S. Levitskaya +3 more
doaj +3 more sources